RE:amarin set backI would not worry about it and really its not bad news, just a delay.....here is what the firm had to say...
The brokerage firm said it isn't surprised by the delay, which comes as the Food and Drug Administration (FDA) plans to hold an advisory committee meeting to discuss the drug. Jefferies believes today's pullback will mark a buying opportunity.
Personally, if I bought a stock at 2 dollars and 50 cents which is sitting at 14 bucks today, even with a 20 percent pull back I would be a very happy camper.